Pages that link to "Q39700360"
Jump to navigation
Jump to search
The following pages link to Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells (Q39700360):
Displaying 33 items.
- Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity (Q21562543) (← links)
- CCR5 monoclonal antibodies for HIV-1 therapy (Q22242739) (← links)
- Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection (Q24194805) (← links)
- Monoclonal CCR5 antibody for treatment of people with HIV infection (Q24235689) (← links)
- Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide (Q24535758) (← links)
- The HIV vaccine saga (Q24805100) (← links)
- Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor (Q33223969) (← links)
- Which Antibody Functions are Important for an HIV Vaccine? (Q33772637) (← links)
- Attachment and Fusion Inhibitors Potently Prevent Dendritic Cell-Driven HIV Infection (Q34574462) (← links)
- Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542. (Q35547693) (← links)
- Enfuvirtide (T-20): A Novel Human Immunodeficiency Virus Type 1 Fusion Inhibitor (Q35549288) (← links)
- In vitro activities of candidate microbicides against cell-associated HIV (Q35689194) (← links)
- Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection (Q35842299) (← links)
- Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide (Q35941336) (← links)
- SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission (Q36059469) (← links)
- Antibody-based inhibitors of HIV infection (Q36446952) (← links)
- Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer (Q36593842) (← links)
- A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells. (Q36673272) (← links)
- Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusion-mediated viral entry (Q36844056) (← links)
- HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells (Q37287774) (← links)
- Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies (Q37583414) (← links)
- Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies (Q38154038) (← links)
- Opportunities for therapeutic antibodies directed at G-protein-coupled receptors (Q39433833) (← links)
- Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals (Q39991496) (← links)
- T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells. (Q40456521) (← links)
- Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site (Q40967581) (← links)
- Interaction between enfuvirtide, an injectable fusion inhibitor, and niacin in an HIV-infected patient (Q42838443) (← links)
- Entry Inhibitors SCH-C, RANTES, and T-20 Block HIV Type 1 Replication in Multiple Cell Types (Q44399525) (← links)
- Inhibitors of fusion: a new alternative in the treatment of HIV infection (Q44903178) (← links)
- The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development (Q46489116) (← links)
- Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy (Q46843503) (← links)
- Dendritic cells efficiently transmit HIV to T Cells in a tenofovir and raltegravir insensitive manner. (Q47205468) (← links)
- Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes (Q80146188) (← links)